Photo by impulsq from unsplash
A 56-year-old Texas rancher with a prior diagnosis of acquired erythropoietic protoporphyria secondary to an underlying myelodysplastic disorder developed an uncommon tumor, blastic plasmacytoid dendritic cell neoplasm (BPDCN). During his… Click to show full abstract
A 56-year-old Texas rancher with a prior diagnosis of acquired erythropoietic protoporphyria secondary to an underlying myelodysplastic disorder developed an uncommon tumor, blastic plasmacytoid dendritic cell neoplasm (BPDCN). During his initial disease, analysis revealed a TET2 mutation, which is the most common mutation associated with BPDCN. This article discusses this unusual hema-topoietic neoplasm, the possible evolution from erythropoietic protoporphyria, and the underlying myelodysplastic process.
Journal Title: Baylor University Medical Center Proceedings
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!